Featured Post

Anti-Fatigue Mats Market Size Worth $1.63 Billion By 2027

IndustryPRwire -- The global anti-fatigue mats market size is expected to reach USD 1.63 billion by 2027 according to a new study by Polaris Market Research . The report “Anti-Fatigue Mats Market Share, Size, Trends, Industry Analysis Report, By Material (Foam Rubber, Hard Rubber, Gel, and Others);…

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

IndustryPRwire -- Co-Diagnostics announced that CoSara Diagnostics, its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (…

Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of GM2 Gangliosidosis With PLX-300

IndustryPRwire -- Polaryx Therapeutics announced that it has received from the U.S. Food and Drug Administration (FDA) both Rare Pediatric Disease and Orphan Drug designations for the treatment of GM…

Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy™ (lonafarnib)

IndustryPRwire -- Eiger BioPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Zokinvy™ (lonafarnib) for the treatment of Hutchinson-Gilford Progeria Syndrome (HGP…

Sciton Announces the Launch of Direct Operations in the United Kingdom

IndustryPRwire -- Sciton® Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies based in Palo Alto, California, USA, is pleased to announce the establishment of d…

RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19

IndustryPRwire -- RedHill Biopharma announced partnerships with two leading, U.S.-based manufacturers for large-scale manufacturing of opaganib. These collaborations further advance ongoing preparati…

BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial of Lead mRNA COVID-19 Vaccine BNT162b2 in China

IndustryPRwire  – BioNTech SE and Shanghai Fosun Pharmaceutical jointly announced that their lead mRNA COVID-19 vaccine candidate BNT162b2 will be evaluated in a Phase 2 clinical trial in Taizhou an…
Newest Older
Subscribe Our Newsletter